Fintel reports that on April 2, 2025, Redburn Atlantic initiated coverage of Quest Diagnostics (NYSE:DGX) with a Buy ...

Redburn Atlantic analyst Jamie Clark initiated coverage of Quest Diagnostics (DGX) with a Buy rating and $195 price target Don't Miss Our End ...

In a report released today, Thomas Flaten from Lake Street reiterated a Buy rating on Aquestive Therapeutics (AQST – Research Report), with a ...

This was the stock's second consecutive day of gains.

The most recent lawsuit is from winter 2024, when the California attorney general announced a $5 million settlement with ...

Thrivent Financial for Lutherans decreased its stake in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 7.1% ...

With a market cap of $18.5 billion, Quest Diagnostics Incorporated (DGX) is a leading provider of diagnostic testing and ...